Compare ARK Genomic Revolution ETF (ARKG) vs RLX Technology Inc (RLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs RLX Technology Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.55, while RLX Technology Inc trades at $1.99 (market cap $2.38B). The key difference: RLX Technology Inc pays a 5.13% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, RLX Technology Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | RLX | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $2.73 |
52-Week Low | $23.09 | $1.79 |
Market Cap | — | $2.38B |
Enterprise Value | — | $1.02B |
Dividend Yield | — | 5.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
RLX trades at $1.95, down 2.01% today, amid mixed technical signals with a neutral overall outlook. The company reported strong 2025 fundamentals with $3.62B revenue and $922M net income, though recent quarterly EPS results have missed expectations. Analyst coverage is limited to a single hold rating, while news highlights international expansion and a cash-rich, debt-free balance sheet.
The outlook is cautious due to earnings misses and a neutral technical stance, but the company's profitability, growth potential in the vaping industry, and solid financial health present a long-term opportunity. Key risks include regulatory pressures and competitive threats in the e-cigarette market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About RLX Technology Inc
RLX Technology Inc. is a leading e-vapor company in China, focusing on the research, development, and sale of e-vapor products. The company primarily operates under the RELX brand, offering a range of closed-system e-vapor products designed to deliver a high-quality user experience. RLX's business model is centered on product innovation, strong brand building, and a vast distribution network across China.
Read more on RLX →
